BRK-B vs GBFH
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
GBFH presents a contradictory profile, characterized by a weak deterministic health baseline with a Piotroski F-Score of 3/9 and a bearish technical trend (0/100). While the company demonstrates strong top and bottom-line growth (Revenue +29.4%, Earnings +37.5% YoY), these fundamentals are undermined by a poor recent earnings track record (only 1 of the last 4 quarters beat estimates). The stock is currently priced at $29.10, sitting between its defensive Graham Number ($19.52) and its growth-based intrinsic value ($43.37). The combination of strong growth and weak financial health/insider sentiment suggests a high-risk, high-reward scenario.
Compare Another Pair
Related Comparisons
BRK-B vs GBFH: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and GBank Financial Holdings Inc. (GBFH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.